Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.

Amy S PallerLisa A BeckAndrew BlauveltElaine C SiegfriedMichael J CorkAndreas WollenbergZhen ChenFaisal A KhokharJignesh VakilAnnie ZhangAshish BansalSonya L Cyr

Published in: Pediatric dermatology (2022)

These data suggest that dupilumab treatment in children and adolescents with AD does not increase infection risk overall and is associated with lower rates of skin infections compared with placebo.

Keyphrases

atopic dermatitis
phase iii
clinical trial
electronic health record
big data
phase ii
open label
study protocol
double blind
randomized controlled trial
soft tissue
machine learning
artificial intelligence
data analysis
placebo controlled
replacement therapy
smoking cessation